Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies.

Hidehito Horinouchi Makoto NishioToyoaki HidaKazuhiko NakagawaHiroshi SakaiNaoyuki NogamiShinji AtagiToshiaki TakahashiHideo SakaMitsuhiro TakenoyamaNobuyuki KatakamiHiroshi TanakaKoji TakedaMiyako SatouchiHiroshi IsobeMakoto MaemondoKoichi GotoTomonori HirashimaKoichi MinatoNaoki SumiyoshiTomohide Tamura

Published in: Cancer medicine (2019)

JapicCTI-132072; JapicCTI-132073.

Keyphrases

advanced non small cell lung cancer
phase ii
clinical trial
epidermal growth factor receptor
open label
case control
phase iii
randomized controlled trial